SecBot SecBot

MDXG

MIMEDX GROUP, INC.
Nasdaq· Surgical & Medical Instruments & Apparatus· CIK 0001376339 Healthcare & Medical Devices
$3.18 −0.03 (−0.93%)
Nov 16 4:00 PM ET · prev $3.21
Market cap
$468.4M
Small cap
Consensus
Buy
91% Buy or better · 11 analysts
Median target
🔒 Subscribers only
1 year
−55.2%
from $7.10 · Nov 17
30 days
−27.4%
from $4.38
52-week range
$3.09–7.25
−56% from high · low Apr 29
Avg volume 20D
1.74M
shares / day
Short interest
8.97M
≈6.2% of shares · −3.2%
Days to cover
4.3
at average volume
Insider net
$0
no open-market trades · 12 mo
New fund stakes
0
Q3 2026 13F · 0 exits
Filing reports
9
analyzed by SecBot
SecBot read BEARISH 6 reports · 90 days
Balance 3 bearish · 1 bullish · 1 mixed · 1 neutral oldest → newest, height = score
Avg score ·High conf. 6/6

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • InstitutionsBULLISH

    Q3 2026: 30 added (0 new), 14 trimmed or exited.

  • AnalystsBULLISH

    10 of 11 rate it Buy or better.

  • Short sellersSTEADY

    Short interest −3.2% to 8.97M shares. 4.3 days to cover, ≈6.2% of shares.

  • TrendDOWNTREND

    25% below its 50-day average.

  • SocialQUIET

    No Reddit mentions this week. Last mention Oct 22.

Who's buying

13F· Q3 2026
0
new positions
0
exits
FundMoveSharesValue
AMERICAN CENTURY COMPANIES INCDOUBLED1,901,087$8.9M
MARSHALL WACE, LLPDOUBLED1,248,009$5.8M
Creative PlanningADD854,900$4.0M
UBS Group AGDOUBLED793,609$3.7M
JANE STREET GROUP, LLCTRIM306,181$1.4M
Quantinno Capital Management LPDOUBLED294,194$1.4M
PRINCIPAL FINANCIAL GROUP INCADD258,642$1.2M
BARCLAYS PLCADD180,950$843.2K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

11 analysts
Buy 91% rate it Buy or better
Strong Buy2Buy8Hold1Sell0Strong Sell0

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access
Recent actions
DateFirmActionRating
Aug 27, 2026Craig-Hallum
MAINTAIN
MAINTAINBuy
Aug 17, 2026Cantor Fitzgerald
REITERATE
REITERATEOverweight
Reddit
Recent posts
All social signals and their track records

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Jul 2, 2026
DOUG RICE
Chief Financial Officer
Jul 2, 2026
TAX W/H$50.4K
Jun 24, 2026
Maersk-Moller Kimberly
Chief Commercial Officer
Jun 24, 2026
TAX W/H$75.9K
Jun 10, 2026
PUHY DOROTHY E
Director
Jun 10, 2026
AWARD$185.3K
Jun 10, 2026
BIERMAN JAMES L
Director
Jun 10, 2026
AWARD$185.3K
Jun 10, 2026
Olson Tiffany
Director
Jun 10, 2026
AWARD$185.3K
Jun 10, 2026
HAWKINS WILLIAM A
Director
Jun 10, 2026
AWARD$185.3K
Jun 10, 2026
Newton Todd
Director
Jun 10, 2026
AWARD$185.3K
Mar 13, 2026
Maersk-Moller Kimberly
Chief Commercial Officer
Mar 13, 2026
TAX W/H$29.6K

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 30, 2026
8,967,651
shares short
-3.2%
vs prior settlement
4.3
days to cover
≈6.2%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 12, 2026 SEC
Trigran Investments, Inc. and its controlling shareholders disclosed a 5.1% passive stake in MiMedx Group via a…
SC 13G · Impact 4/10
Nov 6, 2026 Other
MIMEDX to Participate in Upcoming Investor Conferences
MARIETTA, Ga., Nov. 06, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the
Oct 28, 2026 SEC
MiMedx reported Q3 2026 net sales of $62M, down 45% YoY from $114M, driven by a 71% decline in Wound sales due to…
8-K · Impact 6/10
Oct 28, 2026 SEC
MiMedx reported Q3 2026 net sales of $62M, down 45% YoY from $114M, driven by a 71% decline in Wound Care sales due to…
PRESS-RELEASE · Impact 6/10
Oct 28, 2026 Press
MiMedx Group entered into a patent license agreement with an unnamed wound care competitor, receiving a total of $25…
Impact 5/10
Sep 30, 2026 Inst.
AMERICAN CENTURY COMPANIES INC · DOUBLED
1,901,087 shares ($8.9M)
Sep 30, 2026 Inst.
MARSHALL WACE, LLP · DOUBLED
1,248,009 shares ($5.8M)
Jul 2, 2026 Insider
DOUG RICE surrendered for taxes 12,749 shares
Chief Financial Officer @ $3.95 ($50.4K)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Nov 6, 2026
Press release
MIMEDX to Participate in Upcoming Investor Conferences
MARIETTA, Ga., Nov. 06, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its…
Oct 28, 2026
Earnings
MIMEDX Announces Third Quarter 2026 Operating & Financial Results
Reports Continued Double-Digit Year-Over-Year Volume Growth for Surgical Franchise
Oct 28, 2026
Contract
MIMEDX Announces $25 Million Patent License Agreement
MARIETTA, Ga., Oct. 28, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it has entered…
Oct 28, 2026
Earnings result
MDXG Q3 2026 Earnings: EPS $-0.01 (+26.5% vs est)
Sep 23, 2026
Press release
MIMEDX Announces Favorable Federal Court Ruling in AXIOFILL® Regulatory Classification Matter
Court Vacates FDA Determinations That AXIOFILL Is Not Minimally Manipulated and Should Be Classified as a Biological Product

SecBot reports

9 filings · 1 press release · 1 bullish · 4 bearish · 1 mixed · 3 neutral
All MDXG filing & press-release reports (10)